| Bioactivity | VEGFR-2-IN-37 (compound 12) is an inhibitor of VEGFR-2. The inhibition rate at 200 μM was approximately 56.9 μM. VEGFR-2-IN-37 is a potential inhibitor of human umbilical vein endothelial cell (HUVEC) proliferation[1]. |
| Target | VEGFR-2 |
| Name | VEGFR-2-IN-37 |
| CAS | 298207-77-9 |
| Formula | C18H16N2O2S |
| Molar Mass | 324.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Perspicace E, et al. Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2). Eur J Med Chem. 2013 May;63:765-81. |
VEGFR-2-IN-37
CAS: 298207-77-9 F: C18H16N2O2S W: 324.40
VEGFR-2-IN-37 (compound 12) is an inhibitor of VEGFR-2. The inhibition rate at 200 μM was approximately 56.9 μM. VEGFR
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.